Literature DB >> 13030430

Effects of cancer chemotherapeutic agents on dehydrogenase activity of human cancer tissue in vitro.

M M BLACK, F D SPEER.   

Abstract

Entities:  

Keywords:  DEHYDROGENASES; NEOPLASMS/metabolism in; TRIETHYLENE MELAMINE/effects; URETHANE/effects

Mesh：

Substances：

Year:  1953        PMID： 13030430     DOI： 10.1093/ajcp/23.3.218

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN： 0002-9173            Impact factor:   2.493


× No keyword cloud information.
  11 in total

1.  Apoptosis-related mRNA expression profiles of ovarian cancer cell lines following cisplatin treatment.

Authors:  Joohee Yoon; Eung-Sam Kim; Sung Jong Lee; Chang-Wook Park; Hyung Jin Cha; Bee Hak Hong; Kwan Yong Choi
Journal:  J Gynecol Oncol       Date:  2010-12-31       Impact factor: 4.401

2.  [Morphological and enzymatic changes in a mouse ascites lymphoma with induced resistance].

Authors:  E GATI
Journal:  Z Krebsforsch       Date:  1963

3.  Comparative studies on in vitro human tumor clonogenic assay (HTCA) and in vivo nude mouse-isotope assay (NM-IA).

Authors:  N Hirabayashi; Y Noso; K Niimi; M Nishiyama; M Yamaguchi; T Toge; M Niimoto; T Hattori
Journal:  Jpn J Surg       Date:  1987-03

4.  Efficacy of taxane and platinum-based chemotherapy guided by extreme drug resistance assay in patients with epithelial ovarian cancer.

Authors:  Won Deok Joo; Ji Young Lee; Jong Hyeok Kim; Hang Jo Yoo; Hyun Jin Roh; Jeong-Yeol Park; Dae-Yeon Kim; Yong-Man Kim; Young-Tak Kim; Joo-Hyun Nam
Journal:  J Gynecol Oncol       Date:  2009-06-29       Impact factor: 4.401

Review 5.  In vitro assays for the evaluation of drug resistance in tumor cells.

Authors:  Jozef Hatok; Eva Babusikova; Tatiana Matakova; Dusan Mistuna; Dusan Dobrota; Peter Racay
Journal:  Clin Exp Med       Date:  2008-09-26       Impact factor: 3.984

6.  Sarcophine-diol, a skin cancer chemopreventive agent, inhibits proliferation and stimulates apoptosis in mouse melanoma B₁₆F₁₀ cell line.

Authors:  Pawel T Szymanski; Bhimanna Kuppast; Safwat A Ahmed; Sherief Khalifa; Hesham Fahmy
Journal:  Mar Drugs       Date:  2011-12-22       Impact factor: 6.085

Review 7.  Overview of a chemoresponse assay in ovarian cancer.

Authors:  E C Grendys; J V Fiorica; J W Orr; R Holloway; D Wang; C Tian; J K Chan; T J Herzog
Journal:  Clin Transl Oncol       Date:  2014-07-02       Impact factor: 3.405

8.  A Pilot Study of the Predictive Potential of Chemosensitivity and Gene Expression Assays Using Circulating Tumour Cells from Patients with Recurrent Ovarian Cancer.

Authors:  Stefano Guadagni; Marco Clementi; Francesco Masedu; Giammaria Fiorentini; Donatella Sarti; Marcello Deraco; Shigeki Kusamura; Ioannis Papasotiriou; Panagiotis Apostolou; Karl Reinhard Aigner; Giuseppe Zavattieri; Antonietta Rossella Farina; Giuseppe Vizzielli; Giovanni Scambia; Andrew Reay Mackay
Journal:  Int J Mol Sci       Date:  2020-07-07       Impact factor: 5.923

9.  In vitro drug sensitivity of normal peripheral blood lymphocytes and childhood leukaemic cells from bone marrow and peripheral blood.

Authors:  G J Kaspers; R Pieters; C H Van Zantwijk; P A De Laat; F C De Waal; E R Van Wering; A J Veerman
Journal:  Br J Cancer       Date:  1991-09       Impact factor: 7.640

10.  Mononuclear cells contaminating acute lymphoblastic leukaemic samples tested for cellular drug resistance using the methyl-thiazol-tetrazolium assay.

Authors:  G J Kaspers; A J Veerman; R Pieters; G J Broekema; D R Huismans; K M Kazemier; A H Loonen; M A Rottier; C H van Zantwijk; K Hählen
Journal:  Br J Cancer       Date:  1994-12       Impact factor: 7.640
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.